Principal R&D Engineer
Johns Hopkins School of Medicine & Coram Technologies
Baltimore, Maryland, United States
Luca Neri, Ph.D., MBA, is a biomedical engineer and innovation leader with over 18 years of experience advancing cardiovascular technologies across academic medical centers, early-stage companies, and industry. He currently serves as a Principal R&D Engineer at Coram Technologies, where he leads research and development efforts on next-generation cardiovascular and resuscitation devices, including MRI-conditional defibrillators, CPR systems, and ECMO systems.
Dr. Neri’s work integrates biomedical engineering, translational research, and clinical collaboration. During his time at Johns Hopkins, he contributed to multiple projects at the interface of engineering and cardiology—including the development of advanced electrophysiology tools, physiologic monitoring systems, and AI-enabled algorithms for ECG analysis to detect cardiovascular disease early. He regularly collaborates with electrophysiologists, imaging experts, and cardiologists to transition concepts from prototype to preclinical and FDA-facing evaluation.
In 2025, Dr. Neri was appointed Chief Scientific Officer at Tiba Medical in Washington, D.C., where he directs scientific strategy and innovation in AI and wearable blood pressure monitoring technologies.
Dr. Neri received his BSc in Electronics Engineering, MSc in Biomedical Electronics Engineering, MBA, and PhD in Bioengineering from the University of Bologna, earning the highest distinction for his doctoral dissertation. He later completed professional certifications in Project Management and Technology Entrepreneurship at Johns Hopkins Carey Business School.
A frequent contributor to peer-reviewed publications, Dr. Neri’s scientific work spans cardiovascular diagnostic and interventional devices, signal processing, and AI-driven biosensing. His professional interests include MRI-conditional devices, wearable cardiac monitoring, and the translational pipeline that connects engineering innovation to clinical practice.
Dr. Neri remains committed to advancing cardiovascular science by developing technologies that improve safety, precision, and patient outcomes, and by fostering strong collaborations between engineers, clinicians, and industry partners.
Thursday, February 5, 2026
6:30 PM - 6:40 PM
